(firstQuint)Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer.

 1.

 Determine the response rate with this regimen in an anthracycline and taxane resistant cohort of patients.

 2.

 Determine a maximum tolerated dose of capecitabine in combination with vinorelbine and carboplatin for this patient population.

 3.

 Determine the time to relapse after the administration of this regimen.

.

 Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer@highlight

1.

 Determine the response rate with this regimen in an anthracycline and taxane resistant cohort of patients.

